THERAPEUTIC IMPLICATIONS OF CLOSTRIDIUM DIFFICILE TOXIN DURING RELAPSE OF CHRONIC INFLAMMATORY BOWEL DISEASE
- 1 February 1980
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 315 (8165), 381-383
- https://doi.org/10.1016/s0140-6736(80)90939-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Antibiotic-associated ColitisClinics in Gastroenterology, 1979
- Colitis Induced by Clostridium difficileClinical Infectious Diseases, 1979
- Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.BMJ, 1978
- Role of Clostridium difficile in antibiotic-associated pseudomembranous colitisGastroenterology, 1978
- ORAL VANCOMYCIN FOR ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS COLITISThe Lancet, 1978
- CLOSTRIDIUM DIFFICILE AND THE ÆTIOLOGY OF PSEUDOMEMBRANOUS COLITISThe Lancet, 1978
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978
- Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in HamstersThe Journal of Infectious Diseases, 1977
- Undescribed toxin in pseudomembranous colitis.BMJ, 1977
- Clindamycin-Associated ColitisAnnals of Internal Medicine, 1974